• Products
  • Community
  • Markets
  • Brokers
  • More
Get started
  • Markets
  • /Canada
  • /Stocks
  • /Ideas
Blue digital media to highlight $IBO narrativeThe UI story will be distributed through numerous platforms and audiences by Blue Digital. The expected outcome is increased knowledge of UI's plans to conduct research into the use of ibogaine as part of a continuum of care for opioid addiction and other addictions.
TSXV:IBO
by immediateSnow30226
$IBO an investor’s alluring stock investment$IBO has been elastic through the ebbs and flows of the market and have always maintained a tight toe hold in the Canadian venture exchange, its consistency to this day is what intrigues investors globally, the shares are trading at $0.05 with no such recorded loss
TSXV:IBO
by immediateSnow30226
$IBO with an brilliant profit deliveranceExcellence and IBO always go hand in hand when it comes to proving its potential in the market and leaving competitors way behind the bar. The shares are trading live at $0.05 with a significant spike
TSXV:IBO
by immediateSnow30226
$HEM recoups legal guardianship of its lost intellectual The company has legally retrieved all intellectual data related to stage 2 clinical trial data, along with all previous data from Hemostemix Israel and the randomized table needed to evaluate ACP-01 clinical trial data in North America and South Africa.
TSXV:HEMLong
by spoulhennryy
Universal Ibogaine Inc. (UI) (TSXV: IBO) (OTC: IBOGF) hottest Universal Ibogaine Inc. (UI) (TSXV: IBO) (OTC: IBOGF) hottest stock making heavy profit. Click below link to know more
TSXV:IBOLong
by sparrowhennry951
$IBO Potential Healthcare Stocks That Are Making Investors Insane About The Profit
TSXV:IBOLong
by spoulhennryy
Efficacy of NCP-01 a futuristic product by Hemostemix Neuropathic pain syndromes can be treated with NCP-01 and its autologous stem cell technology, which can treat disorders of the central and peripheral nervous systems. Spinal cord injury, chronic brainstem injury, traumatic brain injury, and peripheral nerve injury are all examples of traumatic injuries and many more
TSXV:HEM
by dasranc777
“An investor without investment ideas is like a traveler without so keep Update your ideas with the new addition of $IBO Update your watch list with the new addition of $IBO Stocks veered from bearish to bullish day by day & leaving investors amazed in the Tsx_v market
TSXV:IBOLong
by spoulhennryy
$HEM grants universal field license to PreCerv Inc. Hemostemix recently granted the global field license of use of NCP-01 and its autologous stem cell therapies to PreCerv Inc. its wholly owned subsidiary to aid patients with peripheral and central nervous system conditions.
TSXV:HEM
by dasranc777
The Universal Ibogaine MissionUniversal Ibogaine is working with Health Canada to undertake a planned clinical trial in Canada to demonstrate the safety and efficacy of the Ibogaine treatment protocol for opioid use disorder.
TSXV:IBO
by immediateSnow30226
$IBO soon to commission ultra- modern addiction treatment centreAt the Kelburn Clinic, UI is developing a cutting-edge holistic addiction treatment protocol that, when combined with the anticipated ibogaine detox programme, will transform the way we treat addiction and dramatically enhance the lives of individuals and families plagued by addiction.
TSXV:IBO
by immediateSnow30226
UI CEO’s thrilled to work with Blue Digital Media"We are happy to have access to Blue Digital's distribution channels, as their range across borders will broaden awareness of our business to new audiences," said Nick Karos, UI's Chief Executive Officer. Because addiction knows no bounds, the remedy we seek must be global in scope." Alike Blue Digital Media’s expertise radar
TSXV:IBO
by immediateSnow30226
Nick Karos excited by listing of UI on Frankfurt stock exchange Universal Ibogaine Inc. CEO made a statement "Our capital markets and investor relations strategy includes the FSE listing. We recently began trading on the OTCQB Exchange in the United States, and curiosity in the UI story is growing in Europe, particularly Germany. With a mushrooming market and interest in psychedelic medications, Germany has a reputation for innovation and leadership."
TSXV:IBOLong
by sparrowhennry951
$IBO CO-Founder with flawless recordDr. Sola, a co-founder of Universal Ibogaine and a member of its Board of Directors, has effectively administered over 3,700 ibogaine treatments, more than any other doctor in the world, at an independent clinic in Cancun, Mexico, where he is a partner.
TSXV:IBO
by immediateSnow30226
$IBO contract with blue digital media dictates further benefitsBlue Digital will be paid USD 27,000 for a three-month commitment beginning June 13, 2022. Additionally, Blue Digital will get 450,000 company's stock options to purchase common shares of the Company, with an exercise price of $0.10 per share, a three-year term, and one-third vesting at the conclusion of each month of service.
TSXV:IBO
by immediateSnow30226
$HEM with a breath taking stock performance on TSX-V$HEM is currently trading on the TSX-V effortlessly at $0.28 with no such loss percentage recorded yet and is expected to rise significantly in the upcoming week effectively.
TSXV:HEM
by immediateSnow30226
$HEM market cap mounts to $19.7 Million strong$HEM have developed and established a firm market cap which has been on the rise steadily since the listing of the stock on TSX-V, currently the cap valuation is $19.773 Million.
TSXV:HEM
by immediateSnow30226
$HEM reports non-brokered private placement of 15 million units Hemostemix disclosed a non-brokered private offering of about 15 million units to shareholders, priced in the context of the market, with each unit consisting of one common share and one common share purchase warrant.
TSXV:HEM
by dasranc777
11
Presentation of Dr. Alberto Sola on the Research to Reality ConfDr. Alberto Sola, the co-founder of $IBOGF is going to present his latest findings in a panel titled “Ibogaine Hydrochloride and Acute Opioid Detox”.
TSXV:IBOLong
by sparrowhennry951
11
Hemostemix Inc. interest payment on convertible debentureHemostemix Inc. announced that it will pay interest of $84,804.40 by issuing 446,339 Common Shares, using the March 2, 2022 closing price of $0.19 per share, to the convertible debenture holder in satisfaction of interest due on the outstanding principal amount of $2,500,000 for the period from inception, June 11, 2021, to December 31, 2021.
TSXV:HEM
by immediateSnow30226
$IBO Market InsightsUniversal Ibogaine Inc. is a Canadian Life science company trading at TSX-V with the ticker symbol $IBO currently sits at $0.0450 with volume around $25K+. invest now for getting higher return
TSXV:IBOLong
by spoulhennryy
11
$PQE moving ahead fiercely with an unstoppable forceThe stock today observed a brief rise in the value per share since its previous close, and the shares are actively being traded on TSX-V at $.245 per unit
P
by immediateSnow30226
$PQE moving ahead fiercely with an unstoppable forceThe stock today observed a brief rise in the value per share since its previous close, and the shares are actively being traded on TSX-V at $.24 per unit
P
by immediateSnow30226
11223344556677
…999999

Select market data provided by ICE Data Services. Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc.Copyright © 2026, American Bankers Association. CUSIP Database provided by FactSet Research Systems Inc. All rights reserved. SEC fillings and other documents provided by Quartr.© 2026 TradingView, Inc.

More than a product
  • Supercharts
Screeners
  • Stocks
  • ETFs
  • Bonds
  • Crypto coins
  • CEX pairs
  • DEX pairs
  • Pine
Heatmaps
  • Stocks
  • ETFs
  • Crypto coins
Calendars
  • Economic
  • Earnings
  • Dividends
More products
  • Yield Curves
  • Options
  • Macro Maps
  • News Flow
  • Pine Script®
Apps
  • Mobile
  • Desktop
Community
  • Social network
  • Wall of Love
  • Refer a friend
  • House Rules
  • Moderators
Ideas
  • Trading
  • Education
  • Editors' picks
Pine Script
  • Indicators & strategies
  • Wizards
  • Freelancers
Tools & subscriptions
  • Features
  • Pricing
  • Market data
  • Gift plans
Trading
  • Overview
  • Top brokers
  • Brokers comparison
Special offers
  • CME Group futures
  • Eurex futures
  • US stocks bundle
About company
  • Who we are
  • Space mission
  • Blog
  • Careers
  • Media kit
Merch
  • TradingView store
  • Tarot cards for traders
  • The C63 TradeTime
Policies & security
  • Terms of Use
  • Disclaimer
  • Privacy Policy
  • Cookies Policy
  • Accessibility Statement
  • Security tips
  • Bug Bounty program
  • Status page
Business solutions
  • Widgets
  • Charting libraries
  • Lightweight Charts™
  • Advanced Charts
  • Trading Platform
Growth opportunities
  • Advertising
  • Brokerage integration
  • Partner program
  • Education program
Community
  • Social network
  • Wall of Love
  • Refer a friend
  • House Rules
  • Moderators
Ideas
  • Trading
  • Education
  • Editors' picks
Pine Script
  • Indicators & strategies
  • Wizards
  • Freelancers
Business solutions
  • Widgets
  • Charting libraries
  • Lightweight Charts™
  • Advanced Charts
  • Trading Platform
Growth opportunities
  • Advertising
  • Brokerage integration
  • Partner program
  • Education program
Look FirstLook First